IgG4相关硬化性胆管炎与原发性硬化性胆管炎的粪便微生物组和代谢组改变
该研究对135例受试者(34例IgG4-SC、37例PSC、64例健康对照)行粪便16S rRNA基因扩增子测序,部分样本行非靶向代谢组学分析。结果显示IgG4-SC和PSC均出现α多样性降低和微生物群落改变,并伴有粪便代谢组差异;整合分析发现两种疾病存在不同的宿主-微生物关联,基于代谢物的预测模型在区分疾病状态方面优于基于微生物的模型。
要点
- IgG4-SC和PSC均表现为肠道菌群α多样性降低及群落结构改变,并伴随粪便代谢组差异。
- IgG4-SC中Blautia耗竭和琥珀酸升高可能与肝脏炎症相关,疾病相关菌属和代谢物倾向于与转氨酶关联。
- PSC中微生物或代谢特征与胆汁淤积指标存在潜在关联,Eubacterium及次级胆汁酸等微生物衍生代谢物一致降低。
核心结论
- IgG4-SC和PSC存在不同的宿主-微生物相互作用,可能参与疾病发病机制,并强调IgG4-SC的独特性。
研究设计与样本
- 对135例受试者(IgG4-SC n=34、PSC n=37、健康对照 n=64)的粪便样本行16S rRNA基因扩增子测序。
- 部分样本(31例IgG4-SC、37例PSC、45例对照)行非靶向代谢组学分析。
主要发现
- 与对照相比,IgG4-SC和PSC均观察到α多样性降低和微生物群落改变,并伴有粪便代谢组差异。
- 整合分析识别出IgG4-SC和PSC中不同的宿主-微生物关联。
- IgG4-SC中疾病相关菌属和代谢物倾向于与转氨酶关联,Blautia明显耗竭和琥珀酸升高可能 underlie 肝脏炎症。
- PSC中检测到微生物或代谢特征与胆汁淤积参数之间的潜在联系,Eubacterium及次级胆汁酸等微生物衍生代谢物一致降低。
- 基于代谢物的预测模型在区分疾病状态方面比基于微生物的模型更有效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Multiple clinical similarities exist between IgG4-related sclerosing cholangitis (IgG4-SC) and primary sclerosing cholangitis (PSC), and while gut dysbiosis has been extensively studied in PSC, the role of the gut microbiota in IgG4-SC remains unknown. Herein, we aimed to evaluate alterations of the gut microbiome and metabolome in IgG4-SC and PSC. DESIGN: We performed 16S rRNA gene amplicon sequencing of faecal samples from 135 subjects with IgG4-SC (n=34), PSC (n=37) and healthy controls (n=64). A subset of the samples (31 IgG4-SC, 37 PSC and 45 controls) also underwent untargeted metabolomic profiling. RESULTS: Compared with controls, reduced alpha-diversity and shifted microbial community were observed in IgG4-SC and PSC. These changes were accompanied by differences in stool metabolomes. Importantly, despite some common variations in the microbiota composition and metabolic activity, integrative analyses identified distinct host-microbe associations in IgG4-SC and PSC. The disease-associated genera and metabolites tended to associate with the transaminases in IgG4-SC. Notable depletion of Blautia and elevated succinic acid may underlie hepatic inflammation in IgG4-SC. In comparison, potential links between the microbial or metabolic signatures and cholestatic parameters were detected in PSC. Particularly, concordant decrease of Eubacterium and microbiota-derived metabolites, including secondary bile acids, implicated novel host-microbial metabolic pathways involving cholestasis of PSC. Interestingly, the predictive models based on metabolites were more effective in discriminating disease status than those based on microbes. CONCLUSIONS: Our data reveal that IgG4-SC and PSC possess divergent host-microbe interplays that may be involved in disease pathogenesis. These data emphasise the uniqueness of IgG4-SC.
引用
- Liu Q, Li B, Li Y, et al. Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis. Gut. 2021. PMID: 34035120. doi:10.1136/gutjnl-2020-323565
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。